As evidenced by extensive research, direct type I interferon-driven vasculopathy plays a central role in the prominent endothelial inflammation in DM, especially with anti-MDA5 antibody (9), which is the highest risk factor for SIH associated with DM (8). The gene discussed is IFIH1; the disease is dermatomyositis.